Nabriva Therapeutics plc Operating Income
Nabriva Therapeutics plc reported Operating Income of -$12.02 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-10-19
- Nabriva Therapeutics plc operating income (loss) for the quarter ending 2023-06-30 was -$12.02M.
- Nabriva Therapeutics plc operating income (loss) for the quarter ending 2023-03-31 was -$8.47M.
- Nabriva Therapeutics plc operating income (loss) for the quarter ending 2022-12-31 was -$22.33M.
- Nabriva Therapeutics plc operating income (loss) for the quarter ending 2022-09-30 was -$11.20M.
- Nabriva Therapeutics plc operating income (loss) for fiscal 2022 was -$55.49M.
- Nabriva Therapeutics plc operating income (loss) for fiscal 2021 was -$48.53M.
- Nabriva Therapeutics plc operating income (loss) for fiscal 2020 was -$66.13M.
- Nabriva Therapeutics plc operating income (loss) for fiscal 2019 was -$79.49M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$12.02M 10-Q · filed 2023-10-19 | -$20.50M 10-Q · filed 2023-10-19 | -$42.83M derived: sum of 3 quarters · filed 2023-10-19 | -$54.03M derived: sum of 4 quarters · filed 2023-10-19 |
| 2023-03-31 | -$8.47M 10-Q · filed 2023-05-22 | -$30.81M derived: sum of 2 quarters · filed 2023-05-22 | -$42.01M derived: sum of 3 quarters · filed 2023-05-22 | -$52.41M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-12-31 | -$22.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$33.53M derived: sum of 2 quarters · filed 2023-04-17 | -$43.93M derived: sum of 3 quarters · filed 2023-10-19 | -$55.49M 10-K · filed 2023-04-17 |
| 2022-09-30 | -$11.20M 10-Q · filed 2022-11-10 | -$21.60M derived: sum of 2 quarters · filed 2023-10-19 | -$33.16M 10-Q · filed 2022-11-10 | -$46.04M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-06-30 | -$10.40M 10-Q · filed 2023-10-19 | -$21.96M 10-Q · filed 2023-10-19 | -$34.84M derived: sum of 3 quarters · filed 2023-10-19 | -$45.66M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-03-31 | -$11.56M 10-Q · filed 2023-05-22 | -$24.44M derived: sum of 2 quarters · filed 2023-05-22 | -$35.26M derived: sum of 3 quarters · filed 2023-05-22 | -$46.64M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | -$12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$23.70M derived: sum of 2 quarters · filed 2023-04-17 | -$35.08M derived: sum of 3 quarters · filed 2023-04-17 | -$48.53M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$10.81M 10-Q · filed 2022-11-10 | -$22.20M derived: sum of 2 quarters · filed 2022-11-10 | -$35.64M 10-Q · filed 2022-11-10 | -$53.91M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-06-30 | -$11.38M 10-Q · filed 2022-08-03 | -$24.83M 10-Q · filed 2022-08-03 | -$43.10M derived: sum of 3 quarters · filed 2023-04-17 | -$56.31M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-03-31 | -$13.45M 10-Q · filed 2022-05-05 | -$31.72M derived: sum of 2 quarters · filed 2023-04-17 | -$44.93M derived: sum of 3 quarters · filed 2023-04-17 | -$59.39M derived: sum of 4 quarters · filed 2023-04-17 |
| 2020-12-31 | -$18.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$31.48M derived: sum of 2 quarters · filed 2023-04-17 | -$45.94M derived: sum of 3 quarters · filed 2023-04-17 | -$66.13M 10-K · filed 2023-04-17 |
| 2020-09-30 | -$13.22M 10-Q · filed 2021-11-09 | -$27.67M derived: sum of 2 quarters · filed 2021-11-09 | -$47.86M 10-Q · filed 2021-11-09 | -$69.93M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$14.45M 10-Q · filed 2021-08-05 | -$34.64M 10-Q · filed 2021-08-05 | -$56.71M derived: sum of 3 quarters · filed 2021-08-05 | -$73.91M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$20.19M 10-Q · filed 2021-05-06 | -$42.26M derived: sum of 2 quarters · filed 2021-05-06 | -$59.46M derived: sum of 3 quarters · filed 2021-05-06 | -$80.43M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$22.07M 10-K · filed 2020-03-12 | -$39.27M derived: sum of 2 quarters · filed 2020-11-05 | -$60.24M derived: sum of 3 quarters · filed 2020-11-05 | -$79.49M 10-K · filed 2022-03-29 |
| 2019-09-30 | -$17.20M 10-Q · filed 2020-11-05 | -$38.17M derived: sum of 2 quarters · filed 2020-11-05 | -$57.42M 10-Q · filed 2020-11-05 | -$88.30M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$20.98M 10-Q · filed 2020-08-06 | -$40.22M 10-Q · filed 2020-08-06 | -$71.10M derived: sum of 3 quarters · filed 2020-08-06 | -$124.02M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$19.24M 10-Q · filed 2020-05-11 | -$50.12M derived: sum of 2 quarters · filed 2020-05-11 | -$103.05M derived: sum of 3 quarters · filed 2020-05-11 | -$120.75M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$30.88M 10-K · filed 2020-03-12 | -$83.80M derived: sum of 2 quarters · filed 2020-03-12 | -$101.51M derived: sum of 3 quarters · filed 2020-03-12 | -$114.38M 10-K · filed 2021-03-11 |
| 2018-09-30 | -$52.92M 10-K · filed 2020-03-12 | -$70.63M derived: sum of 2 quarters · filed 2020-03-12 | -$83.50M 10-Q · filed 2019-11-12 | -$105.78M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$17.71M 10-K · filed 2020-03-12 | -$30.57M 10-Q · filed 2019-08-08 | -$52.85M derived: sum of 3 quarters · filed 2020-03-12 | -$73.58M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$12.86M 10-K · filed 2020-03-12 | -$35.15M derived: sum of 2 quarters · filed 2020-03-12 | -$55.87M derived: sum of 3 quarters · filed 2020-03-12 | -$71.43M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$22.28M 10-K · filed 2019-03-12 | -$43.01M derived: sum of 2 quarters · filed 2019-03-12 | -$58.57M derived: sum of 3 quarters · filed 2019-03-12 | -$73.77M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$20.73M 10-K · filed 2019-03-12 | -$36.29M derived: sum of 2 quarters · filed 2019-03-12 | -$51.49M 10-Q · filed 2018-11-06 | -$66.23M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$15.56M 10-K · filed 2019-03-12 | -$30.76M 10-Q · filed 2018-08-09 | -$45.50M derived: sum of 3 quarters · filed 2019-03-12 | -$59.58M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$15.20M 10-K · filed 2019-03-12 | -$29.94M derived: sum of 2 quarters · filed 2019-03-12 | -$44.02M derived: sum of 3 quarters · filed 2019-03-12 | -$55.55M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$14.74M 10-K · filed 2018-03-16 | -$28.82M derived: sum of 2 quarters · filed 2018-03-16 | -$40.34M derived: sum of 3 quarters · filed 2018-03-16 | -$55.05M 10-K · filed 2019-03-12 |
| 2016-09-30 | -$14.08M 10-K · filed 2018-03-16 | -$25.61M derived: sum of 2 quarters · filed 2018-03-16 | -$40.31M 10-Q · filed 2017-11-09 | -$50.55M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$11.53M 10-K · filed 2018-03-16 | -$26.23M 10-Q · filed 2017-08-07 | -$36.47M derived: sum of 3 quarters · filed 2018-03-16 | -$44.80M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$14.70M 10-K · filed 2018-03-16 | -$24.94M derived: sum of 2 quarters · filed 2018-03-16 | -$33.27M derived: sum of 3 quarters · filed 2018-03-16 | -$38.79M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$10.24M 10-K · filed 2017-03-24 | -$18.57M derived: sum of 2 quarters · filed 2017-03-24 | -$24.09M derived: sum of 3 quarters · filed 2017-03-24 | -$27.76M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$8.33M 10-K · filed 2017-03-24 | -$13.85M derived: sum of 2 quarters · filed 2017-03-24 | -$17.52M derived: sum of 3 quarters · filed 2017-03-24 | |
| 2015-06-30 | -$5.52M 10-K · filed 2017-03-24 | -$9.19M derived: sum of 2 quarters · filed 2017-03-24 | ||
| 2015-03-31 | -$3.67M 10-K · filed 2017-03-24 | |||
| 2014-12-31 | -$10.70M 10-K · filed 2017-03-24 |